Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S573000, C549S079000, C562S503000

Reexamination Certificate

active

07906552

ABSTRACT:
A compound comprisingor a pharmaceutically acceptable salt or a prodrug thereof, having the groups described in detail herein is disclosed.Also disclosed herein are compounds comprisingor derivatives thereof, or pharmaceutically acceptable salts, tetrazoles, or prodrugs of compounds of the structure or derivatives thereof, said derivatives being described in detail herein.Also disclosed herein are methods of treating diseases or conditions, including glaucoma and elevated intraocular pressure. Compositions and methods of manufacturing medicaments related thereto are also disclosed.

REFERENCES:
patent: 4055602 (1977-10-01), Nelson
patent: 4119727 (1978-10-01), Buendia et al.
patent: 4141914 (1979-02-01), Grudzinskas et al.
patent: 4166452 (1979-09-01), Generales, Jr.
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 4994274 (1991-02-01), Chan et al.
patent: 5028624 (1991-07-01), Chan et al.
patent: 5034413 (1991-07-01), Chan et al.
patent: 5446041 (1995-08-01), Chan et al.
patent: 5599838 (1997-02-01), Sato et al.
patent: 5741810 (1998-04-01), Burk
patent: 5834498 (1998-11-01), Burk
patent: 5972991 (1999-10-01), Burk
patent: 6124344 (2000-09-01), Burk
patent: 6248773 (2001-06-01), Burk
patent: 6376533 (2002-04-01), Burk et al.
patent: 6448290 (2002-09-01), Ohuchida et al.
patent: 6586462 (2003-07-01), Burk et al.
patent: 6649657 (2003-11-01), Cameron et al.
patent: 6680337 (2004-01-01), Burk
patent: 2002/0094981 (2002-07-01), Ponticello et al.
patent: 2523676 (1976-12-01), None
patent: 2626888 (1977-04-01), None
patent: 27 19 244 (1977-11-01), None
patent: 2616304 (1977-11-01), None
patent: 2719244 (1977-11-01), None
patent: 53135955 (1978-11-01), None
patent: WO 99/25358 (1999-05-01), None
patent: WO 02/100388 (2002-12-01), None
patent: WO 03/002755 (2003-01-01), None
Patani et al. “Bioisosterism: A Rational Approach in Drug Design” Chem Rev, 1996, vol. 96, pp. 3147-3176.
Grudzinskas et al. “Prostaglandins and Congeners IV. The Synthesis of Certain 11-Substituted Derivatives of 11-Deoxyprostaglandin E2 and F2a From 15-O-Acetylprostaglandin A2 Methyl Ester” Tetrahedron Letters, 1973, pp. 141-144.
Bito, L.Z.Biological Protection with Prostaglandins, Cohen, M.M., ed., Boca Raton, Fla, CRC Press Inc., 1985, pp. 231-252.
Bito, L.Z.,Applied Pharmacology in the Medical Treatment of GlaucomasDrance, S.M. and Neufeld, A.H. eds., New York, Grune & Stratton, 1984, pp. 477-505.
Bito, L.Z.,Arch. Ophthalmol. 105, 1036 (1987).
Francis A. Carey, Organic Chemistry, New York: McGraw-Hill Book Company 1987, p. 63.
Nilsson et. al.,Invest. Ophthalmol. Vis. Sci. (suppl), 284 (1987).
Siebold et al.,Esterified Prostaglandin Shows ‘Potent’ Promise, Ocular Surgery News, vol. 1, No. 3 (Feb. 1989); pp. 3, 59.
Bartmann, et al., “Luteolytic Prostaglandins Sysnthesis and bilogical Activity,” Feb. 1979, vol. 27, No. 2, pp. 301.
Office Action in U.S. Appl. No. 10/915,987 Date Mailed Jan. 11, 2006.
Notice of Allowance in U.S. Appl. No. 10/915,987 Date Mailed May 2, 2006.
Notice of Allowance in U.S. Appl. No. 10/915,933 Date Mailed Nov. 1, 2006.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2705415

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.